GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 142 filers reported holding GERON CORP in Q2 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $17,000 | -10.5% | 12,660 | -12.2% | 0.00% | – |
| Q3 2019 | $19,000 | +5.6% | 14,415 | +13.0% | 0.00% | – |
| Q2 2019 | $18,000 | -10.0% | 12,760 | +1.7% | 0.00% | – |
| Q1 2019 | $20,000 | +66.7% | 12,550 | +7.3% | 0.00% | – |
| Q4 2018 | $12,000 | +20.0% | 11,700 | +98.3% | 0.00% | – |
| Q3 2018 | $10,000 | +42.9% | 5,900 | +168.2% | 0.00% | – |
| Q2 2018 | $7,000 | -22.2% | 2,200 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | +80.0% | 2,200 | -20.0% | 0.00% | – |
| Q4 2017 | $5,000 | -58.3% | 2,750 | -47.1% | 0.00% | – |
| Q3 2017 | $12,000 | -42.9% | 5,200 | -29.7% | 0.00% | – |
| Q2 2017 | $21,000 | +133.3% | 7,400 | +76.2% | 0.00% | – |
| Q1 2017 | $9,000 | -10.0% | 4,200 | -19.2% | 0.00% | – |
| Q4 2016 | $10,000 | +11.1% | 5,200 | +23.8% | 0.00% | – |
| Q3 2016 | $9,000 | -25.0% | 4,200 | -16.0% | 0.00% | – |
| Q2 2016 | $12,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |